 |
PDBsum entry 2bfh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Growth factor
|
PDB id
|
|
|
|
2bfh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Biochem (tokyo)
110:360-363
(1991)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of basic fibroblast growth factor at 1.6 A resolution.
|
|
H.Ago,
Y.Kitagawa,
A.Fujishima,
Y.Matsuura,
Y.Katsube.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have determined the crystal structures of two types of human basic fibroblast
growth factor, the serine analogue and the wild-type, at 1.6 and 2.5 A
resolution, respectively. Two good heavy atom derivatives were found and used
for multiple isomorphous replacement phasing. The atomic coordinates were
refined using the Hendrickson & Konnert program for stereochemically
restrained refinement against structure factors. The crystallographic R factors
were reduced to 15.3% for the serine analogue structure and 16.0% for the
wild-type structure. The serine analogue and wild-type structures have been
found to be almost identical, the root-mean-square deviation between the
corresponding C alpha atoms being 0.11 A. Their structures are composed of
twelve beta-strands forming a barrel and three loops. Their molecules have an
approximate threefold internal symmetry and are similar in architecture to that
of interleukin-1 beta. A possible heparin-binding site, which comprises five
basic residues, Lys119, Arg120, Lys125, Lys129, and Lys135, has been revealed by
calculating the electrostatic potential energy.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Renko,
J.Sabotic,
M.Mihelic,
J.Brzin,
J.Kos,
and
D.Turk
(2010).
Versatile loops in mycocypins inhibit three protease families.
|
| |
J Biol Chem,
285,
308-316.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
U.Freudenberg,
A.Hermann,
P.B.Welzel,
K.Stirl,
S.C.Schwarz,
M.Grimmer,
A.Zieris,
W.Panyanuwat,
S.Zschoche,
D.Meinhold,
A.Storch,
and
C.Werner
(2009).
A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases.
|
| |
Biomaterials,
30,
5049-5060.
|
 |
|
|
|
|
 |
Q.Zhang,
G.J.Wang,
and
J.G.Sun
(2004).
Pharmacokinetics of recombinant human basic fibroblast growth factor in mice using a radioiodination method combined with SDS-PAGE and a sandwich enzyme-linked immunosorbent assay.
|
| |
Eur J Drug Metab Pharmacokinet,
29,
163-168.
|
 |
|
|
|
|
 |
H.J.Hecht,
R.Adar,
B.Hofmann,
O.Bogin,
H.Weich,
and
A.Yayon
(2001).
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
378-384.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.R.Brych,
S.I.Blaber,
T.M.Logan,
and
M.Blaber
(2001).
Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.
|
| |
Protein Sci,
10,
2587-2599.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.M.Patrie,
M.J.Botelho,
K.Franklin,
and
I.M.Chiu
(1999).
Site-directed mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1.
|
| |
Biochemistry,
38,
9264-9272.
|
 |
|
|
|
|
 |
P.J.Kim,
K.Sakaguchi,
H.Sakamoto,
C.Saxinger,
R.Day,
P.McPhie,
J.S.Rubin,
and
D.P.Bottaro
(1998).
Colocalization of heparin and receptor binding sites on keratinocyte growth factor.
|
| |
Biochemistry,
37,
8853-8862.
|
 |
|
|
|
|
 |
S.Faham,
R.J.Linhardt,
and
D.C.Rees
(1998).
Diversity does make a difference: fibroblast growth factor-heparin interactions.
|
| |
Curr Opin Struct Biol,
8,
578-586.
|
 |
|
|
|
|
 |
F.J.Moy,
M.Safran,
A.P.Seddon,
D.Kitchen,
P.Böhlen,
D.Aviezer,
A.Yayon,
and
R.Powers
(1997).
Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
|
| |
Biochemistry,
36,
4782-4791.
|
 |
|
|
|
|
 |
B.S.Chang,
R.M.Beauvais,
T.Arakawa,
L.O.Narhi,
A.Dong,
D.I.Aparisio,
and
J.F.Carpenter
(1996).
Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.
|
| |
Biophys J,
71,
3399-3406.
|
 |
|
|
|
|
 |
F.J.Moy,
A.P.Seddon,
P.Böhlen,
and
R.Powers
(1996).
High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.
|
| |
Biochemistry,
35,
13552-13561.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Venkataraman,
V.Sasisekharan,
A.B.Herr,
D.M.Ornitz,
G.Waksman,
C.L.Cooney,
R.Langer,
and
R.Sasisekharan
(1996).
Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.
|
| |
Proc Natl Acad Sci U S A,
93,
845-850.
|
 |
|
|
|
|
 |
P.M.Smallwood,
I.Munoz-Sanjuan,
P.Tong,
J.P.Macke,
S.H.Hendry,
D.J.Gilbert,
N.G.Copeland,
N.A.Jenkins,
and
J.Nathans
(1996).
Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development.
|
| |
Proc Natl Acad Sci U S A,
93,
9850-9857.
|
 |
|
|
|
|
 |
Y.Kato,
T.Muto,
T.Tomura,
H.Tsumura,
H.Watarai,
T.Mikayama,
K.Ishizaka,
and
R.Kuroki
(1996).
The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.
|
| |
Proc Natl Acad Sci U S A,
93,
3007-3010.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Arakawa,
P.Holst,
L.O.Narhi,
J.S.Philo,
J.Wen,
S.J.Prestrelski,
X.Zhu,
D.C.Rees,
and
G.M.Fox
(1995).
The importance of Arg40 and 45 in the mitogenic activity and structural stability of basic fibroblast growth factor: effects of acidic amino acid substitutions.
|
| |
J Protein Chem,
14,
263-274.
|
 |
|
|
|
|
 |
D.F.Kusewitt,
C.L.Sabourin,
C.L.Budge,
T.E.Sherburn,
and
R.D.Ley
(1994).
Characterization of cDNA encoding basic fibroblast growth factor of the marsupial Monodelphis domestica.
|
| |
DNA Cell Biol,
13,
549-554.
|
 |
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
and
B.W.Matthews
(1993).
Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.
|
| |
Protein Sci,
2,
1274-1284.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Zhu,
B.T.Hsu,
and
D.C.Rees
(1993).
Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor.
|
| |
Structure,
1,
27-34.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |